Advertisement

Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post–allogeneic HCT

Mohammad Abu Zaid, Juan Wu, Cindy Wu, Brent R. Logan, Jeffrey Yu, Corey Cutler, Joseph H. Antin, Sophie Paczesny and Sung Won Choi

Article Information

Citation 
vol. 129 no. 2 162-170
PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted August 22, 2016
  • Accepted October 26, 2016
  • Published online January 12, 2017.

Article Versions


Contributors 
  • Mohammad Abu Zaid, 1Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN; 2Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis, IN;
  • Juan Wu, 3The Emmes Corporation, Rockville, MD;
  • Cindy Wu, 3The Emmes Corporation, Rockville, MD;
  • Brent R. Logan, 4Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI;
  • Jeffrey Yu, 1Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN; 2Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis, IN;
  • Corey Cutler, 5Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and
  • Joseph H. Antin, 5Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and
  • Sophie Paczesny, 1Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN; 2Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis, IN;
  • Sung Won Choi, 6Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output